Edwards Lifesciences Fundamental Drivers

Edwards Lifesciences Corporation -- USA Stock  

USD 113.08  1.05  0.94%

The Drivers Module shows relationships between Edwards Lifesciences's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Edwards Lifesciences Corporation over time as well as its relative position and ranking within its peers. Additionally see Investing Opportunities

Edwards Lifesciences Earnings Per Share vs. Working Capital Fundamental Analysis

Edwards Lifesciences Corporation is rated # 4 in working capital category among related companies. It is rated below average in earnings per share category among related companies . The ratio of Working Capital to Earnings Per Share for Edwards Lifesciences Corporation is about  476,272,727 
Working Capital is measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Edwards Lifesciences 
Working Capital 
 = 
Current Assets 
Current Liabilities 
=
1.57 B
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Edwards Lifesciences 
Earnings per Share 
 = 
Earnings 
Average Shares 
=
3.3 times
Earnings per Share is one of the most important measures of the current share price of a firm, and is used by investors to determine the company overall profitability; especially when it is compared to the EPS of similar companies.

Comparison

Earnings Per Share Comparison
Edwards Lifesciences is rated # 5 in earnings per share category among related companies.

Revenue

Edwards Lifesciences Revenue Analysis
Edwards Lifesciences Corporation is rated below average in revenue category among related companies. Market size based on revenue of Healthcare Products industry is currently estimated at about 284.59 Billion. Edwards Lifesciences claims roughly 3.23 Billion in revenue contributing just under 2% to equities under Healthcare Products industry.
Edwards Lifesciences Corporationration offer solutions and technologies to treat structural heart disease and critically ill patients worldwide. more
NameEdwards Lifesciences Corporation
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
InstrumentUSA Stock Stocks Directory
RegionNorth America
ExchangeNew York Stock Exchange
CIK Number01099800.0
ISINUS28176E1082
CUSIP28176E108
CurrencyUSD - US Dollar
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Find Alpha
Equity Screener
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
Research Equities
Insiders Screener
Find insiders across different sectors to evaluate their impact on performance and growth of their entities
Research Insiders